Search This Blog

Tuesday, May 19, 2026

Tiziana intranasal foralumab well tolerated with favorable disability trends in non-active MS

Tiziana Life Sciences reports intranasal foralumab well tolerated with favorable disability trends in 14 non-active MS patients

  • Updated Expanded Access data show clinically meaningful fatigue improvements and disability stabilization in 14 non-active SPMS patients.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)